Molecular Templates to Present at the Oppenheimer 28th Annual Healthcare Conference

Molecular Templates to Present at the Oppenheimer 28th Annual Healthcare Conference

AUSTIN, Texas, March 19, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq:MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new class of targeted biologic therapies that possess unique mechanisms of action in oncology, today announced that its management will provide a corporate overview at the Oppenheimer 28th Annual Healthcare Conference, taking place March 20-21 at the Westin New York Grand Central hotel in New York City.

   
Presentation Details  
Date: Wednesday, March 21
Time: 10:20am Eastern Time
Location: Track 3
   

About Molecular Templates  

Molecular Templates is focused on the discovery, development and commercialization of next-generation immunotoxins called Engineered Toxin Bodies (ETBs) for the treatment of cancers and other serious diseases.  For additional information, please visit Molecular Templates’ website at www.mtem.com.

Investor Contact:
Andrew McDonald, Ph.D.
[email protected]
646-597-6987

Adam Cutler
Chief Financial Officer
[email protected]
862-204-4006